Acasti Pharma Reports Second Quarter FY 2018 Financial Results
LAVAL, QUEBEC--(Marketwired - Nov 13, 2017) - Acasti Pharma Inc. (NASDAQ:ACST)(TSX VENTURE:ACST), a biopharmaceutical innovator focused on the research, development and commercialization of its prescription drug candidate CaPre® (omega-3 phospholipid) for …